Soleno Therapeutics (SLNO) Announces Presentation of Positive Behavioral Data from Ongoing Extension Study of DCCR for Treatment of Prader-Willi Syndrome

Go back to Soleno Therapeutics (SLNO) Announces Presentation of Positive Behavioral Data from Ongoing Extension Study of DCCR for Treatment of Prader-Willi Syndrome
(NASDAQ: SLNO) Delayed: 1.10 --0 (-0%)
Previous Close $1.10    52 Week High
Open $1.11    52 Week Low
Day High $1.11    P/E N/A 
Day Low $1.10    EPS
Volume 29,966